May 2023

Huge Medicare reimbursement cuts hit electrophysiology | Bullying, harassment & discrimination in cardiology ()
Care Delivery Highlights: Lawsuits in cardiology | How working at a hospital influences cardiologists ()
TAVR among 90-year-old patients: An updated look at mortality & more | FDA approves new heart failure drug ()
Cardiologist compensation keeps climbing | Key takeaways from Heart Rhythm 2023 | AI for heart failure data ()
A historic procedure | New TAVR valve's strong 1-year performance | AI & electrophysiology | More from the last week ()
Heart Rhythm Highlights: AI gaining popularity | Cardiologists make history, implant new dual cardiac device ()
Plant-based diets linked to key health benefits | Medtronic's $738M acquisition | New AUC for chronic coronary disease ()
Cardiac Imaging Highlights: Cardiology embracing AI | CT-guided PCI | ASE releases new training standards ()
New TAVR valve, the first of its kind, linked to strong 1-year performance | AI & electrophysiology ()
Dual-chamber leadless pacemaker impresses researchers | Predicting heart disease ()
Tiny device enables leadless CRT | Expert consensus on remote monitoring | LBB pacing ()
Cleveland Clinic cardiologists make history | ‘Promising’ results with new device | Concerning heart transplant data ()
The first heart procedure of its kind | Embracing AI | Innovation in the cath lab | More from the last week ()
Heart Health Highlights: Cardiologists compare popular diets | Marijuana & PAD | Artificial sweeteners & CVD ()
Marijuana use increases PAD risk | Busy cardiology group inks another deal | Abbott's new FDA approval ()
New data on TEER, TAVR & PCI from EuroPCR 2023 | Stroke deaths expected to rise | Medtronic’s Harmony TPV ()
Interventional Cardiology Highlights: Making history | Shockwave acquisition updates | PCI access ()
Innovation in the cath lab | WHO warns against use of artificial sweeteners | Bayer's new AFib drug ()
Cardiologists make history | Doc arrested for sexual assault again, now linked to 10 alleged victims | AFib ablation ()
Vascular & Endovascular Highlights: How working at a hospital influences care | Abbott completes $850M deal ()
Cardiology embracing AI | Next-gen TAVR valve tested on patients for first time | TVT 2023 ()
News on a potential Shockwave Medical deal | Cardiac imaging trends | ChatGPT | More from the last week ()
TAVR Highlights: Concerns about treating low-risk patients | New data on repeat TAVR | Native AR ()
AI & cardiac imaging | 2 more vendors consider Shockwave Medical acquisition | Heart Rhythm 2023 ()
1 in 3 cardiologists have been sued | AI predicts LVEF during routine coronary angiograms ()
Structural Heart Disease Highlights: Cardiologists make history | Radiation exposure in the cath lab | Redo TAVR ()
Trends in cardiac imaging | Cardiologist arrested on suspicion of murder | FDA expands dapagliflozin approval ()
Nobel Prize winner tells his story | Shockwave Medical deal reportedly hits snag | FDA clears Samsung AFib alerts ()
Heart Failure Highlights: New HFpEF recommendations released as cases keep rising | Risks tied to NSAID use ()
ChatGPT excels with thoracic surgery data | PCI access & heart attack outcomes | Cardiac tech at HIMSS ()
Cardiologist salaries | Statin use & inflammation | TAVR concerns | A key approval for Medtronic | More from the last week ()
How working at a hospital influences cardiologists | Comparing heart-healthy diets | $55M in funding ()
Avertix Medical announces plan to go public | SCCT honors Martha Gulati | FDA clears toilet seat-based heart monitor ()
News Alert: Avertix Medical, known for its implantable devices, to go public with initial value of $195M ()
Economics Highlights: The highest-paying job in the US | New bill would limit Medicare cuts | Tracking TAVR costs ()
Is TAVR too common among younger patients? | FDA approves next-gen leadless pacemakers | New 'e-tattoo' heart tech ()
April's Most Popular Stories: A historic procedure | Multiple recalls | The highest-paying job in the US | Much more! ()
Statin use & inflammation | Heart surgeon charged with 'professional incompetency' | Another PE-backed deal hits cardiology ()